Method of and a composition for treatment of latent virus infection
CA 2077966 A1 · Owner: Mark, David · Inventors: Thompson, Kathleen A.; Goldberg, Dennis I.; Rowe, W. Bruce
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a method for and a composition for treating viral infections associated with periods of viral latency. More specifically the present, invention provides a prophylactic therapy to maintain the virus in a latent state and an active treatment of recurrent viral reactivation that will facilitate a return to viral latency. Pursuant to the present invention a, noncysteine substrate is administered as a composition to a patient having a latent viral infection in an amount sufficient to increase the intracellular glutathione levels of the cells of a patient that harbors a latent or active virus.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 10, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 10, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 10, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.